Mucopolysaccharidosis Iv

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-12-19
Clinical Trial Update: Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI [Phase 2]
Phase 2 study evaluating the effect of losartan on cardiovascular outcomes in patients with Mucopolysaccharidosis IV A and VI.